MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,124,359 | -2.1% | 80,254 | +0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,147,977 | -52.2% | 80,222 | -14.8% | 0.01% | -50.0% |
| Q3 2022 | $2,403,000 | -8.3% | 94,126 | +2.0% | 0.01% | 0.0% |
| Q2 2022 | $2,620,000 | -9.2% | 92,237 | +12.7% | 0.01% | +33.3% |
| Q1 2022 | $2,887,000 | -16.3% | 81,841 | -0.6% | 0.01% | 0.0% |
| Q4 2021 | $3,450,000 | -17.6% | 82,329 | -3.5% | 0.01% | -10.0% |
| Q3 2021 | $4,189,000 | +19.3% | 85,349 | +1.5% | 0.01% | +25.0% |
| Q2 2021 | $3,510,000 | +15.6% | 84,109 | -1.3% | 0.01% | 0.0% |
| Q1 2021 | $3,037,000 | +25.4% | 85,223 | -1.2% | 0.01% | +33.3% |
| Q4 2020 | $2,421,000 | – | 86,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |